Infant formula is expensive, so it’s helpful to find ways to save money on baby formula. CR shares 10 tips for parents and ...

A new Consumer Reports investigation of infant formulas found that some of the products tested contained potentially harmful levels of arsenic and lead. CR also found per- and polyfluoroalkyl ...

Their exclusive testing found that some formulas contained dangerous levels of heavy metals. Of the formulas tested, 21 had little to no detectable heavy metals, including Enfamil Gentlease, Similac ...

The FDA would embark on a comprehensive look at the nutrients used in infant formula and increase testing for heavy metals and other contaminants, HHS said in its statement.

The FDA and HHS announced "Operation Stork Speed" Tuesday, which aims to increase testing for heavy metals and other contaminants in baby formula.

"I tried different formulas because I wanted to give her the best nutrients," said new mother Linda Ramirez. Sign up for our Newsletters Consumer Reports analyzed 41 types of powdered formula to help ...

CR’s investigative team examined popular formula brands, including Enfamil, Similac, Bobbie, and store-brand options, testing for toxins like arsenic, lead, BPA, acrylamide, and PFAS (commonly ...

In 2022 Abbott detected contamination at one of its formula manufacturing plants, which led to a recall and national shortage of the vital source of newborn nutrition. And in 2023 Reckitt/Mead ...

The formulation of Primal Queen is rooted in the concept of whole-food nutrition, emphasizing the importance of nutrient density found in animal organs. Bovine organ powders are known for their ...

Standing next to a chart that looked like it was pulled from a group project gone wrong, Johnson’s Trump attempted to decode its symbols. “That’s a triangle,” he said. “I don’t know ...

Equities haven't performed well this year due to a combination of factors. Macroeconomic tensions are at the top of that list. Still, some companies are doing just fine amid the volatility ...

Abbott Laboratories, a healthcare giant with a market capitalization of $229.45 billion, reported its first-quarter 2025 earnings, surpassing expectations with an adjusted earnings per share (EPS ...